Pittsburgh-based NeuBase is diverting resources from its Huntington’s program and shedding 60% of its workforce in a strategic restructuring, the company announced Friday.
Posts
As the economy ebbs and flows, pharma and biotech companies alike are feeling the pressure to cut costs. From rapid inflation to the ever-changing regulatory landscape, many are looking for ways to reduce their burn rate.
